105 related articles for article (PubMed ID: 8094619)
1. Differential activity of the RVF enhancer element in the decreased expression of the neu oncogene in NR-6 cells versus parental Swiss Webster 3T3 cells.
Yan DH; Hung MC
Mol Carcinog; 1993; 7(1):44-9. PubMed ID: 8094619
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a novel enhancer for the rat neu promoter.
Yan DH; Hung MC
Mol Cell Biol; 1991 Apr; 11(4):1875-82. PubMed ID: 1672439
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
4. Negative autoregulation of the neu gene is mediated by a novel enhancer.
Zhao XY; Hung MC
Mol Cell Biol; 1992 Jun; 12(6):2739-48. PubMed ID: 1350324
[TBL] [Abstract][Full Text] [Related]
5. Cloning and activation of the Syrian hamster neu proto-oncogene.
Nakamura T; Ushijima T; Ishizaka Y; Nagao M; Arai M; Yamazaki Y; Ishikawa T
Gene; 1994 Mar; 140(2):251-5. PubMed ID: 7908275
[TBL] [Abstract][Full Text] [Related]
6. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
Stern DF; Heffernan PA; Weinberg RA
Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
[TBL] [Abstract][Full Text] [Related]
7. The retinoblastoma gene product suppresses neu oncogene-induced transformation via transcriptional repression of neu.
Yu D; Matin A; Hung MC
J Biol Chem; 1992 May; 267(15):10203-6. PubMed ID: 1350277
[TBL] [Abstract][Full Text] [Related]
8. Stage- and tissue-specific expression of the neu oncogene in rat development.
Kokai Y; Cohen JA; Drebin JA; Greene MI
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8498-501. PubMed ID: 3317411
[TBL] [Abstract][Full Text] [Related]
9. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
Sistonen L; Hölttä E; Lehväslaiho H; Lehtola L; Alitalo K
J Cell Biol; 1989 Nov; 109(5):1911-9. PubMed ID: 2572601
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
Sikes RA; Chung LW
Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of the mouse neu promoter.
White MR; Hung MC
Oncogene; 1992 Apr; 7(4):677-83. PubMed ID: 1348855
[TBL] [Abstract][Full Text] [Related]
12. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence.
Matin A; Hung MC
Oncogene; 1994 May; 9(5):1333-9. PubMed ID: 7908732
[TBL] [Abstract][Full Text] [Related]
13. Regulation of c-myb oncogene expression in immature and mature murine T cells.
Mountz JD; Subler MA
Mol Immunol; 1993 Jun; 30(9):787-95. PubMed ID: 8321245
[TBL] [Abstract][Full Text] [Related]
14. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.
Kokai Y; Myers JN; Wada T; Brown VI; LeVea CM; Davis JG; Dobashi K; Greene MI
Cell; 1989 Jul; 58(2):287-92. PubMed ID: 2568888
[TBL] [Abstract][Full Text] [Related]
16. Trans-activation of the mouse cytomegalovirus immediate early gene enhancer by ras oncogenes.
Lembo D; Angeretti A; Foresta P; Gribaudo G; Gariglio M; Landolfo S
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1685-92. PubMed ID: 8021597
[TBL] [Abstract][Full Text] [Related]
17. A chimeric EGFR/neu receptor in studies of neu function.
Lehtola L; Lehväslaiho H; Koskinen P; Alitalo K
Cancer Treat Res; 1992; 61():213-28. PubMed ID: 1360234
[No Abstract] [Full Text] [Related]
18. Activation of a muscle-specific enhancer by the Ski proto-oncogene.
Engert JC; Servaes S; Sutrave P; Hughes SH; Rosenthal N
Nucleic Acids Res; 1995 Aug; 23(15):2988-94. PubMed ID: 7659522
[TBL] [Abstract][Full Text] [Related]
19. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
Connelly PA; Stern DF
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6054-7. PubMed ID: 1974718
[TBL] [Abstract][Full Text] [Related]
20. c-myc reverses neu-induced transformed morphology by transcriptional repression.
Suen TC; Hung MC
Mol Cell Biol; 1991 Jan; 11(1):354-62. PubMed ID: 1670896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
